CollPlant Biotechnologies Non-GAAP EPS of -$0.33, revenue of $2.23M misses by $0.31M

* CollPlant Biotechnologies press release [https://seekingalpha.com/pr/20206173-collplant-biotechnologies-reports-2025-second-quarter-financial-results-and-provides] (NASDAQ:CLGN [https://seekingalpha.com/symbol/CLGN]): Q2 Non-GAAP EPS of -$0.33.
* Revenue of $2.23M (+537.1% Y/Y) misses by $0.31M.

MORE ON COLLPLANT BIOTECHNOLOGIES

* CollPlant shares rise on expanded partnership with STEMCELL Technologies [https://seekingalpha.com/news/4456468-collplant-shares-rises-on-expanded-partnership-with-stemcell-technologies]
* CollPlant Biotechnologies shares slide after announces capital raise of $3.6M through registered direct offering [https://seekingalpha.com/news/4453806-collplant-biotechnologies-shares-slide-after-announces-capital-raise-3_6m-through-registered]
* Seeking Alpha’s Quant Rating on CollPlant Biotechnologies [https://seekingalpha.com/symbol/CLGN/ratings/quant-ratings]
* Historical earnings data for CollPlant Biotechnologies [https://seekingalpha.com/symbol/CLGN/earnings]
* Financial information for CollPlant Biotechnologies [https://seekingalpha.com/symbol/CLGN/income-statement]